In the rat of CUMS model, rTMS treatment significantly improved anxiety and depression-like behavior and reduced the levels of inflammatory factors TNF-α, iNOS, IL-1β, and IL-6 in the hippocampus [24]. This evidence concerns the gene IL6 and major depressive disorder.